Research location
Wels
Austria
Advertisement
Research activity in Wels
AustriaCureCurrent currently publishes aggregate city-level research activity for this location: 123 trials and 123 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Wels
123 linked trials · page 2 of 3Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHFNCT01870778 · 2013-10-02 · 1 site observation
COMPLETED
An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)NCT01853826 · 2013-07-17 · 1 site observation
COMPLETED
Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®NCT01803555 · 2013-07-04 · 1 site observation
COMPLETED
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast CancerNCT01740336 · 2013-02-06 · 1 site observation
COMPLETED
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 DiabetesNCT01541215 · 2012-11-13 · 1 site observation
COMPLETED
Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLCNCT01673867 · 2012-11-02 · 1 site observation
COMPLETED
Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)NCT01642004 · 2012-10-16 · 1 site observation
COMPLETED
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller MedicationNCT01696071 · 2012-09-01 · 1 site observation
COMPLETED
A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaNCT01578707 · 2012-06-01 · 1 site observation
COMPLETED
Abraxane in Treatment of Metastatic Breast CancerNCT02555696 · 2012-05-31 · 1 site observation
COMPLETED
A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of ActionNCT01638715 · 2012-05-01 · 1 site observation
COMPLETED
Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical PracticeNCT01524900 · 2012-03-01 · 1 site observation
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to MethotrexateNCT01587989 · 2012-02-01 · 1 site observation
COMPLETED
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.NCT01475721 · 2011-11-18 · 1 site observation
COMPLETED
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerNCT01358877 · 2011-11-08 · 1 site observation
COMPLETED
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaNCT01444456 · 2011-10-01 · 1 site observation
COMPLETED
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)NCT01351415 · 2011-06-25 · 1 site observation
COMPLETED
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent AsthmaNCT01316380 · 2011-03-01 · 1 site observation
COMPLETED
A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe AsthmaNCT01311661 · 2011-03-01 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 1 site observation
COMPLETED
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The LungNCT01154140 · 2011-01-13 · 1 site observation
COMPLETED
Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung CancerNCT01244191 · 2011-01-11 · 1 site observation
TERMINATED
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based ChemotherapyNCT01168973 · 2010-12-01 · 1 site observation
COMPLETED
A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent AsthmaNCT01152450 · 2010-07-01 · 1 site observation
COMPLETED
Safety and Clinical Performance of the Protecta ICD and CRT-DNCT00982397 · 2009-09-01 · 1 site observation
COMPLETED
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR MutationNCT00949650 · 2009-08-14 · 1 site observation
COMPLETED
Efficacy and Safety of Pulsed Infusions of Levosimendan in Outpatients With Advanced Heart FailureNCT01065194 · 2009-08-01 · 1 site observation
UNKNOWN
European Study of Cardiovascular RiskNCT00882336 · 2009-05-01 · 1 site observation
COMPLETED
A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung CancerNCT00867009 · 2009-04-01 · 1 site observation
COMPLETED
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD PatientsNCT00789854 · 2008-11-01 · 1 site observation
COMPLETED
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of PioglitazoneNCT00763815 · 2008-09-01 · 1 site observation
COMPLETED
Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic DrugsNCT01083693 · 2008-09-01 · 1 site observation
COMPLETED
PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.NCT00736502 · 2008-09-01 · 1 site observation
COMPLETED
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00722267 · 2008-07-01 · 1 site observation
COMPLETED
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus BevacizumabNCT00625898 · 2008-04-01 · 1 site observation
TERMINATED
Pulsatile and Steady State Hemodynamics in Diastolic Heart FailureNCT00720525 · 2008-04-01 · 1 site observation
COMPLETED
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate CancerNCT00626548 · 2008-01-01 · 1 site observation
TERMINATED
BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast CancerNCT00528567 · 2007-12-01 · 1 site observation
COMPLETED
Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 MonthsNCT00561509 · 2007-11-01 · 1 site observation
COMPLETED
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation
TERMINATED
AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line ChemotherapyNCT00547651 · 2007-09-01 · 1 site observation
COMPLETED
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With HerceptinNCT01152606 · 2007-08-30 · 1 site observation
COMPLETED
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast CancerNCT00553410 · 2007-08-01 · 1 site observation
COMPLETED
Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer PatientsNCT00511459 · 2007-07-01 · 1 site observation
COMPLETED
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 DiabetesNCT00469092 · 2007-05-01 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate CancerNCT00537381 · 2007-05-01 · 1 site observation
COMPLETED
Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer PatientsNCT00798070 · 2007-02-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast CancerNCT00435409 · 2007-02-01 · 1 site observation
COMPLETED
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)NCT00409188 · 2007-01-01 · 1 site observation
COMPLETED
Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)NCT00406302 · 2007-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.